NeRRe Therapeutics
Develops clinical and pre-clinical neurokinin receptor antagonists.
Launch date
Employees
Market cap
-
Enterprise valuation
€138m (Public information from Jul 2021)
Company register number 07916206
Stevenage England (HQ)
Authorizing premium user...